Glenn Welling - MEDIFAST INC Independent Director
| MED Stock | USD 32.47 0.59 1.85% |
Director
Mr. Glenn W. Welling serves as Independent Director of the company. Mr. Welling is the founder and Chief Investment Officer of Engaged Capital. Prior to Engaged Capital, Mr. Welling was a Principal and Managing Director at Relational Investors, from June 2008 to October 2011, Prior to Relational Investors, Mr. Welling served as a Managing Director at Credit Suisse, from February 2002 to June 2008 as the Head of the Investment Banking Departments Advisory Business. At Credit Suisse, he built his group from two to fifty people and into one of the leading commercially focused advisory businesses on Wall Street. Mr. Welling was an advisor on over 100 billion of transactions in his last year there. Mr. Welling joined Credit Suisse when the Firm acquired HOLT Value Associates L.P., where he was a Partner and Managing Director from 1999 to 2002. At HOLT, he ran the Corporationrationrate and Alliance Services business, advising senior executives and Boards on how their decisions would be viewed and valued by institutional investors. Prior to HOLT, he was the Managing Director of Valuad U.S., a financial software and training company, from 1997 to 1999. Prior to leading Valuad U.S., Mr. Welling worked at a number of leading strategy consulting firms including A.T. Kearney and Marakon Associates. He has worked and managed businesses in the United States, Europe and Asia since 2015.
| Age | 45 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Address | 100 International Drive, Baltimore, MD, United States, 21202 |
| Phone | 410 581 8042 |
| Web | https://medifastinc.com |
Glenn Welling Latest Insider Activity
Tracking and analyzing the buying and selling activities of Glenn Welling against MEDIFAST INC stock is an integral part of due diligence when investing in MEDIFAST INC. Glenn Welling insider activity provides valuable insight into whether MEDIFAST INC is net buyers or sellers over its current business cycle. Note, MEDIFAST INC insiders must abide by specific rules, including filing SEC forms every time they buy or sell MEDIFAST INC'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Glenn Welling over three months ago Acquisition by Glenn Welling of 26 shares of MEDIFAST INC subject to Rule 16b-3 | ||
Glenn Welling over six months ago Sale by Glenn Welling of 251950 shares of MEDIFAST INC |
MEDIFAST INC Management Efficiency
The company has Return on Asset of 0.2524 % which means that on every $100 spent on assets, it made $0.2524 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5577 %, implying that it generated $0.5577 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.34. The current year's Return On Capital Employed is expected to grow to 0.61. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 15.4 M, whereas Net Tangible Assets are forecasted to decline to about 125 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Domenico Sole | Newell Brands | 72 | |
| William McGlashan | ELF Beauty | 53 | |
| Steven Strobel | Newell Brands | 59 | |
| Wei Christianson | Estee Lauder Companies | 64 | |
| Russell Greenberg | Inter Parfums | 61 | |
| Christopher OLeary | Newell Brands | 55 | |
| Andrew Langham | Newell Brands | 42 | |
| Richelle Parham | ELF Beauty | 53 | |
| Debra Crew | Newell Brands | 47 | |
| Swan Sit | Edgewell Personal Care | 43 | |
| Francois Heilbronn | Inter Parfums | 57 | |
| Lauren Levitan | ELF Beauty | 54 | |
| Kirk Perry | ELF Beauty | 53 | |
| Judith Sprieser | Newell Brands | 64 | |
| Raymond Viault | Newell Brands | 71 | |
| Carla Hendra | Edgewell Personal Care | 64 | |
| Stephen Ellis | ELF Beauty | 55 | |
| Robert Black | Edgewell Personal Care | 61 | |
| Maureen Watson | ELF Beauty | 52 | |
| Richard Parsons | Estee Lauder Companies | 72 | |
| Gary Waring | Edgewell Personal Care | 61 | |
Management Performance
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.25 |
MEDIFAST INC Leadership Team
Elected by the shareholders, the MEDIFAST INC's board of directors comprises two types of representatives: MEDIFAST INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEDIFAST. The board's role is to monitor MEDIFAST INC's management team and ensure that shareholders' interests are well served. MEDIFAST INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEDIFAST INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Margaret Sheetz, President COO, Director | ||
| Ming Xian, Independent Director | ||
| Brian Kagen, Chief Marketing Officer and Executive VP | ||
| Anthony Tyree, Chief Marketing Officer | ||
| Michael Hoer, Independent Director | ||
| Timothy Robinson, Chief Financial Officer | ||
| Jeffrey Brown, Lead Independent Director | ||
| Fran Lawler, Chief Human Resource Officer | ||
| Lauren Walker, Executive Vice President - Supply Chain Operations | ||
| Glenn Welling, Independent Director | ||
| Jason Esq, General VP | ||
| Jason Groves, Executive Vice President, General Counsel, Corporate Secretary | ||
| Joseph Kelleman, Interim Chief Financial Officer, Vice President - Finance | ||
| Charles Connolly, Independent Director | ||
| James Maloney, Chief Financial Officer, Interim Principal Accounting Officer | ||
| Tony Tyree, Chief Marketing Officer | ||
| Donald Gould, Executive VP of Information Technology | ||
| Michael MacDonald, Chairman, CEO and Chairman of Executive Committee | ||
| Jeanne City, Executive Vice President - Human Resources | ||
| Jonathan Mackenzie, Chief Accounting Officer | ||
| Daniel Chard, Executive Chairman of the Board, Chief Executive Officer | ||
| James CPA, Chief Officer | ||
| Mehrnaz Ameli, President - Take Shape For Life | ||
| Bill Baker, Executive Vice President Information Technology | ||
| William Baker, Executive Vice President Information Technology | ||
| Stephen Johnson, Chief Accounting Officer, Vice President - Finance | ||
| Andrea Thomas, Independent Director | ||
| Steven Zenker, Vice Relations | ||
| Scott Schlackman, Independent Director | ||
| Kevin Byrnes, Independent Director | ||
| Carl Sassano, Independent Director | ||
| Constance Hallquist, Independent Director | ||
| Nicholas Johnson, Executive Vice President - Coach Success, Market President of OPTAVIA USA | ||
| Claudia Greninger, Executive Vice President - Human Resources |
MEDIFAST Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEDIFAST INC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.25 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 222.05 M | ||||
| Shares Outstanding | 10.9 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 97.40 % | ||||
| Number Of Shares Shorted | 2.66 M | ||||
| Price To Earning | 13.99 X |
MEDIFAST INC Investors Sentiment
The influence of MEDIFAST INC's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in MEDIFAST. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to MEDIFAST INC's public news can be used to forecast risks associated with an investment in MEDIFAST. The trend in average sentiment can be used to explain how an investor holding MEDIFAST can time the market purely based on public headlines and social activities around MEDIFAST INC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
MEDIFAST INC's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for MEDIFAST INC's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average MEDIFAST INC's news discussions. The higher the estimated score, the more favorable is the investor's outlook on MEDIFAST INC.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MEDIFAST INC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MEDIFAST INC's short interest history, or implied volatility extrapolated from MEDIFAST INC options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.